The respiratory chain Complex I deficiencies are the most common cause of mitochondrial diseases. Complex I biogenesis is controlled by 58 genes and at least 47 of these cause mitochondrial disease in humans. Two of these are X-chromosome linked nuclear (nDNA) genes (NDUFA1 and NDUFB11), and 7 are mitochondrial (mtDNA, MT-ND1-6, -4L) genes, which may be responsible for sex-dependent variation in the presentation of mitochondrial diseases. In this study, we describe an X-chromosome linked mouse model (Ndufa1
Introduction
The deficiencies of the respiratory chain Complex I (NADHubiquinone oxidoreductase) are the most common cause of mitochondrial diseases. This may be because Complex I is composed of 45 subunits encoded by 37 nuclear (nDNA, 1 subunit in duplicate) genes and 7 mitochondrial (mtDNA) genes. In addition, at least 14 assembly factors or chaperones are required for Complex I biogenesis (Alston, CL, 2017) . Complex I deficiency can arise due to mutations in nDNA and mtDNA. While the majority of mitochondrial diseases are due to hereditary mutations, they are also found associated with de novo mutations. At least 47 Complex I-associated genes are reported to cause mitochondrial disease (Alston, CL, 2017) . Only two of these are X-chromosome-linked genes, the NDUFA1 and NDUFB11. Respectively, they encode "accessory or supernumerary subunits" MWFE (or NDUFA1) and ESSS (or NDUFB11) Zhuchenko et al., 1996) . Both MWFE and ESSS are essential for Complex I assembly and function (Au et al., 1999; Potluri et al., 2004; Yadava et al., 2002) . Mutations in both genes cause mitochondrial disease in humans (Fernandez-Moreira et al., 2007; Lichtenstein et al., 2016; Mayr et al., 2011; Potluri et al., 2009; Torraco et al., 2017; Uehara et al., 2014) . There is male bias in the presentation of Complex I-related mitochondrial diseases. This sex bias may result from mutations in X-chromosome linked genes and/or maternally inherited mtDNA (Bu and Rotter, 1991; Horvath et al., 2006; Hudson et al., 2005; Wittig et al., 2001) .
The severity of mitochondrial diseases varies with the degree of respiratory chain deficiency. While severe deficiencies are often fatal in early life, the mild deficiencies remain asymptomatic up to adulthood and later in life (Chinnery, 2015) . The factors that trigger diseases in individuals with mild-to-moderate Complex I deficiencies are poorly understood. Drug toxicities and infections are thought to be key contributors to mitochondrial disease onset (Cohen, 2010; Cohen and Saneto, 2012; Cope et al., 2011; Garone et al., 2011) .
Complex I deficiency is also implicated in age-associated neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, cancer, and diabetes (Giachin et al., 2016; Iommarini et al., 2013; Wallace, 2005) . Our studies have shown that even minimal inhibition of Complex I can increase susceptibility to excitotoxic death in primary neurons (Yadava and Nicholls, 2007) . Loss of Purkinje neurons and cerebellar atrophy are thought to be due to excitotoxic damage in mitochondrial encephalomyopathies (Quattrocchi et al., 2016) . Environmental exposures such as pesticides increase susceptibility to neurodegeneration by impairing Complex I (Betarbet et al., 2000) . Interactions of both genetic and environmental factors may determine an individual's susceptibility to age-dependent diseases by influencing Complex I and other components of the oxidative phosphorylation.
Genetic animal models are required to understand the pathogenic mechanisms elicited by inherited Complex I deficiency. These animal models should represent severe to mild Complex I deficiencies and be based on different genes. Such models will enable understanding of the mechanisms of early to late-onset mitochondrial diseases, genotype-phenotype correlation, sex bias, and the conditions that trigger disease onset. In particular, mice models with heritable mutations in X-chromosome-and mtDNA-encoded Complex I genes can help understand the basis of sex bias in disease presentation. There are two mice models with heritable mutations in mtDNA-encoded ND6 subunit of Complex I (Fan et al., 2008; Hashizume et al., 2012; Lin et al., 2012) . However, a genuine X-chromosome linked model for Complex I deficiency is lacking.
In this study, we report an X-chromosome linked mouse model for systemic partial Complex I deficiency. This is based on knock-in of the Ndufa1 S55A allele by homologous recombination at Ndufa1 gene locus on the X-chromosome. The MWFE subunit encoded by Ndufa1 is required for Complex I assembly (Yadava et al., 2002 . The Ndufa1 S55A allele encodes serine-55 to alanine (S55A) substitution in MWFE protein, which reduces Complex I assembly by~50% in Chinese hamster cells (Yadava et al., 2008) . Therefore, this mutation was introduced in mouse MWFE to model systemic partial Complex I deficiency. As expected, mutant (Ndufa1 ) mutants showed different survival patterns. Metabolic profiling showed reduced levels of heme in tissues of mutant mice. This correlated with reduced ferrochelatase (Fech) mRNA in liver and increased heme oxygenase (Hmox 1) mRNA in brain and liver. The Fech expression was reduced across two different genetic backgrounds (129 and BALB/c).
Materials & methods

Ndufa1
S55A knock-in strategy 129/SvEv-derived male embryonic stem cells (ES) were used to target the Ndufa1 S55A allele on its native locus at X-chromosome.
The Ndufa1 S55A knock-in construct (KI Neo) is shown in Fig. 1A . The Ndufa1 S55A allele harbors a point mutation in the codon-55 (T > G;
codon TCT > GCT). The long homology arm was 6.0 kb upstream to the point mutation (T > G) in exon 2. The LoxP/FRT-Neo cassette for G418 selection was inserted 903 bp downstream of the point mutation within intron 2e3. The short homology arm extended 2.0 kb from the 5'-end of the Neo cassette. The T > G mutation was created by site-directed mutagenesis. ES clones with correct targeting by homologous recombination were screened first by polymerase chain reaction (PCR) and later confirmed by Southern blot analysis with an internal probe. Genomic DNA was digested with HpaI, and electrophoretically separated on a 0.8% agarose gel. After transfer to a nylon membrane, the digested DNA was hybridized with a probe targeted against the 3 0 internal region (Fig. 1B) . DNA from 129/SvEv was used as wild type control. The expected sizes for wild-type (WT; 9.3 kb) and knock-in (KI Neo: 11 kb) are shown (Fig. 1A) . Because ES cells were derived from male mice, only one copy of the Ndufa1 gene was expected. Therefore, correct targeting will result in only one band of 11 kb. By Southern blot analysis clone #253 was identified to have Ndufa1 S55A allele correctly targeted at its native locus (Fig. 1B) . After confirming the reduced MWFE and Complex I levels in ES clone #253 (data not shown), it was injected into C57BL/6 blastocysts. Chimeras with high percentage agouti coat color were mated to 129 FLP mice (JAX #003946) to remove the Neo-cassette (KI, Fig. 1A ) and simultaneously generate the germline founder mice. A mutant male (Ndufa1 S55A/Y ) and two heterozygous females (Ndufa1
) were obtained. They were crossed with wild type mice (129S1/SvImJ, Jackson Laboratory, Stock #02448) to expand the colony. The deletion of Neo-cassette was confirmed by PCR screening using primers set F1 (5 0 -CAA AGC CAT TTC TCT GCC TCT-3 0 ) and R1 (5 0 -CCA AAA AAC CTC ACT CAC AAC C-3'; Fig. 1C , Top). The presence of Ndufa1 S55A allele was confirmed using primers set F2 (5' -TGA GCT ATC TCT TCA GCC TCT AG-3 0 ) and R2 (5 0 -GAC CCT GTC TCA ATT ACA AAT CAA CCA ACC -3 0 ) by Hyp188III restriction fragment length polymorphism (Fig. 1C , Bottom). The Hyp188III cuts only wild type (Ndufa1 þ ) allele. Finally, the presence of T > G mutation in the Ndufa1 S55A mice was confirmed by DNA sequencing (not shown). From gene targeting to founder mice generation, this project was supported by inGenious Targeting Laboratory (Stony Brook, NY) on pay for services basis (Project # 962-NDUF). The Ndufa1 S55A allele was transferred from 129 to BALB/c background by backcrossing for 9 generations (N9). The transfer of allele was monitored by genotyping as described below.
Genotyping
Routine genotyping was carried out by PCR using F1 and R1 primers (see sequence above). They give a product larger than wild type copy (Fig. 1C, Top) . To isolate genomic DNA, mouse tail tips (0.5 cm) were incubated in 500 ml of tail digestion buffer (1 M Tris, pH 8, 0.5 M EDTA, 5 M NaCl, and 10% SDS) containing 100 mg/ml of proteinase K and incubated overnight with rotation at 55 C. After 5 min centrifugation at 13,000 rpm the supernatant was collected, and DNA was precipitated by adding 500 ml of isopropanol. The precipitated DNA was washed with 70% ethanol, air-dried, dissolved in Tris-EDTA buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). 1 mg DNA was used with PCR mixture (Roche Cat#:04738420001), primers (F1, R1, 1 mM each), and DNA polymerase and amplification of DNA was performed for 35 cycles. After 5 min denaturation of DNA at 99 C polymerase was added and 35 cycles of denaturation, annealing, and extension at 95 C, 60 C and 99 C respectively were performed using a BioRad C1000 thermal cycler. An alternative strategy based on hybridization probe analysis for single nucleotide polymorphism (SNP) detection was also used (Takatsu et al., 2004) . Ndufa1 was amplified using Toughmix QPCR mix (forward primer TGCTCGTGTTCAGTACCAGTG, reverse primer GCATTACCA-GAAGCCACCAC, mutant probe AGACGTATCGCTGGAGT, wild-type probe TAGACGTATCtCTGGAGTCA) and run on a Roche LightCycler 480 with conditions suggested for Toughmix amplification. Analysis was performed using the endpoint module of the Roche LightCycler 480 Software, release 1.5.1. The wild-type amplicon was detected on the X axis with the FAM filter and the mutant amplicon was detected on the Y axis with the Hex filter. This was performed by Genotyping Center of America (Ellsworth, ME) on pay for services basis.
Animal care and metabolic phenotyping
The mice were housed at Baystate animal care facility under protocols (IACUC #132694 for breeding, and #178325 for experiments) and Children Hospital of Pennsylvania (CHOP) animal care facility under protocol (#IAC16-000925). They were housed at (22 ± 2 C) and 12 h light and dark cycles. Free access to water and food was made available. For metabolic phenotyping, the control and Ndufa1 S55A mice were sent to the Penn Diabetes Research Center where they were housed individually in calorimeter cages and allowed unlimited access to food and water. Food intake, energy metabolism, and locomotor activity were measured with the Comprehensive Laboratory Animal Monitoring System (Columbus Instruments, OH) as described Chutkow et al., 2010; Jurczak et al., 2011) . Energy metabolism was estimated based on monitoring of oxygen consumption (vO 2 ) and carbon dioxide production (vCO 2 ). From the gas exchange data, the respiratory exchange ratio (RER ¼ vCO 2 /vO 2 ) and energy expenditure (EE ¼ 3.815 þ 1.232 Â RER) were calculated. Mice were acclimatized to cages for two days before undergoing 24 h of monitoring. Data was collected every 40 s on all mice simultaneously.
Mouse embryonic fibroblasts (MEFs) preparation
MEFs were prepared by setting timed pregnancies for controls
) and mutants (Ndufa1 S55A/Y x Ndufa1 S55A/ S55A ) crosses separately. At 15 days post-coitus, the dams were anesthetized and fetuses were surgically removed and placed in sterile phosphate buffered saline. Then the dams were euthanized. Next brains, hearts and livers from fetuses were removed. The remaining parts of fetuses were finely minced using a sterile razor blade and incubated with 0.25% trypsin/EDTA for 5e10 min at 37 C. Cells were dissociated by pipetting in/out during the incubation. Then trypsin was inactivated adding complete DMEM medium containing 10% FBS and penicillin-streptomycin antibiotics. Cells were harvested by centrifuging at 300 Â g for 5 min, re-suspended and cultured in warm DMEM medium (Passage 0). Experiments were performed with MEFs within passages 1e3.
Mitochondria isolation, electrophoresis and western blotting
Liver, brain, and skeletal muscle mitochondria were isolated as described (Trounce et al., 1996) . Western blot analyses following the sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) or blue native polyacrylamide gel electrophoresis (BN-PAGE) were performed as we have described elsewhere (Yadava et al., 2002 . For BN-PAGE analysis mitochondria were either solubilized with sodium dodecyl b-D maltoside (2 mg detergent/mg protein) or digitonin (8 mg detergent/mg protein) for monitoring assembled Complex I alone (monomer) or with its super-complexes respectively. Indicated proteins/respiratory complexes were detected using specific antibodies. All primary S55A knock-in Strategy. Homology arms, the T > G point mutation in the 55th codon TCG for serine-55 (*), and LoxP/FRTNeo cassette for selection are shown. The T > G mutation in exon 2 (*) was created by site-directed mutagenesis. The probe (P), HpaI sites (H), and primers (F1-R1, F2-R2) used for Southern blotting and PCR are indicated. B) ES cell clones screening by Southern blotting using probe P for correct targeting. Clone #253 was used for deriving Ndufa1 S55A mice by injecting into C57BL/6 blastocysts. C) Mice genotyping by PCR. The deletion of Neo-cassette was confirmed by PCR using primers F1-R1 (top panel). The presence of Ndufa1 S55A allele was confirmed by PCR using primers F2-R2 (bottom panel). Additional confirmation was made with DNA sequencing (not shown).
antibodies were used at 1:1000 dilution except anti-MWFE (1:4000). All secondary antibodies were used at 1:5000 dilutions. Bands were quantified by Syngene G-box imaging system and its proprietary software.
Respirometry
Respiratory activities of isolated mitochondria, and intact and permeabilized cells were measured using XF24 Agilent-Seahorse Extracellular Flux Analyzer (Gerencser et al., 2009; Kim et al., 2014) -free LKB made by excluding CaCl 2 and adding 1 mM ethyleneglycol-tetra-acetic acid (EGTA) with 0.4% BSA was used for assessing the respiration of permeabilized cells and isolated mitochondria. 5 mg mitochondria/well and 10,000 MEFs/ well were used for assays. They were spun down into V7 PS culture plates and respirometry was performed after 30 min (mitochondria) or 4 h (MEF) as described (Rogers et al., 2011) . Complex Idependent respiration was measured using glutamate þ malate as substrates (10 mM, each). Complex II-dependent respiration was measured using 10 mM succinate as substrate. Cells were permeabilized with 1 nM recombinant perfringolysin O (rPFO) as described (Kim et al., 2014) . The substrates for Complex I or II were added along with 1 mM ADP and 3 mM FCCP to record maximal respiratory activities of isolated mitochondria and permeabilized cells.
Histopathology
Brain tissues extracted from two pairs of two-year-old litter mate control and mutant mice were fixed in paraformaldehyde, paraffin-embedded, and cut into 8 sections. Sections were stained with hematoxylin and eosin (H&E), and evaluated under the microscope. This was performed at Wistar Institute on pay for services basis (Philadelphia, PA). Tissues from young mice were stained with H&E and evaluated using in-house histopathology core facility at Pioneer Valley Life Sciences Institute (Springfield, MA).
Rotarod test
Motor coordination and strength were assessed with a Rotarod apparatus (Med Associates, St. Albans, VT). Rotarod consisted of a plastic rod, 6 cm in diameter and 36 cm long, with a non-slippery surface 20 cm above a base tip plate. The mice were trained at constant rotating speeds of 16 rpm and 24 rpm in 4 consecutive trials per day. On the fourth day, the mice were tested in multiple trials at an accelerating speed (from 0 to 40 rpm) over 5 min. The mean latency to fall from the Rotarod was automatically recorded by the apparatus. Mice that remained on the rod for the full 300 s were thereafter removed and scored with a latency of 300 s. Data are presented as the mean latency to fall from the accelerating rod over 4 consecutive trials.
Metabolomics
The metabolic profiles of liver, brain and serum were performed by Metabolon Inc. (Durham, NC) on pay for services basis (Project # PVLS-01-12VW). Brain (n ¼ 12), liver (n ¼ 12) and sera (n ¼ 6) were shipped from our laboratory to Metabolon with dry ice, which upon arrival were stored at À80 C until processed. Samples were prepared using MicroLab STAR system from Hamilton Company. Recovery standards were added prior to the first step of extraction for quality control. Metabolon's standard solvent extraction method involving proprietary series of organic and aqueous extractions was used to remove protein fraction while allowing maximal recovery of small molecules. Samples were split into equal parts for analysis on GC/MS and LC/MS/MS analyses. Several replicate samples created from a homogenous pool containing a small amount of all study samples were also included on both platforms ("Client Matrix"). Instrument variability was determined by calculating the median relative standard deviation (RSD) for the internal standard added to each sample prior to injection into mass spectrometers. The overall process variability was determined by calculating RSD for all endogenous metabolites (i.e. noninstrument standards) present in the Client Matrix. Median RSD for instrument variability was 4% for all tissues. The overall process variability was 11% for brain and liver, and 12% for serum. After log transformation and imputation with minimum observed values for each compound, Welch's two sample t-test was used to identify biochemicals that differed significantly between wild type control (WT) and mutant (S55A) male mice.
Quantitative reverse-transcriptase (qRT)-PCR
The qRT-PCR for quantitating mRNA expression of different genes was performed as we have described previously (Compton et al., 2011) . Respectively forward and reverse primers used were 5 0 -ACC TTC TCC GTG GTG GCT-3 0 and 5 0 -GGA AAT GCT TTC GGC CAG-3 0 for Fech, 5 0 -CTC GGC TTG GAT GTG TAC CT-3 0 and 5 0 -GAG CAG AAC CAG CCT GAA CT-3 0 for Hmox1, 5 0 -ACC AGA GGC ATA CAG GGA CA and 5 0 -CTA AGG CCA ACC GTG AAA AG-3 0 for b-actin, 5 0 -CAG GCC CTT GGA CAC ATA GT-3 0 , and 5 0 -GTC CAC TGC GTA CAT CCA CA-3 0 for Ndufa1, 5 0 -TTG AGG TCA ATG AAG GGG TC-3 0 and 5 0 -TCG TCC CGT AGA CAA AAT GG-3 0 for Gapdh. These primers were designed for mouse-specific gene sequences.
Data analysis
Data were analyzed using either Microsoft Excel 2010 or GraphPad Prism 5. Comparisons between two groups were made using unpaired student's t-test. Data are either shown as mean ± SD or sem as indicated.
Results
Development of the Ndufa1
S55A model
To develop mice harboring systemic and partial Complex I deficiency, we introduced the Ndufa1 S55A allele in mouse chromosome at its native locus as described in the Materials and Methods section. Briefly, the Ndufa1 S55A allele bearing a point mutation in codon-55 (TCT > GCT) was knocked in by homologous recombination using the strategy shown in Fig. 1A . ES clone #253 was used to generate mouse chimeras, which were crossed with 129 FLP mice (129S4/SvJaeSor-Gt(ROSA)26Sor ) females. In mutants, Complex I level was reduced by~70%,~60% and 35% in brain, heart, and liver, respectively (normalized relative to Complex II except for heart; Fig. 2D ). To determine how respiratory super-complexes were affected by the S55A mutation, we used digitonin solubilized mitochondria for BN-PAGE analysis. The monomeric Complex I was recognized by running sodium dodecyl b-D-maltoside solubilized mitochondria side-by-side with the digitonin solubilized mitochondria (not shown). We observed that both monomeric Complex I and its associated super-complexes were reduced in mutants (Fig. 2E) . Together, these data demonstrate that Ndufa1 S55A allele causes systemic partial Complex I deficiency in mice. The reductions in MWFE protein, and Complex I assembly and activity by the S55A were in agreement with our previous study in cell culture (Yadava et al., 2008) . Because above data are based on isolated mitochondria, they are far from physiological conditions. Therefore, to assess the impact of Ndufa1 S55A allele on Complex I function close to physiological conditions, we performed in-situ respirometry with embryonic fibroblasts (MEFs). The wild-type (WT) and mutant (S55A) mice derived MEFs were compared side-by-side in respirometric assays using the XF24 Analyzer (Gerencser et al., 2009; Wu et al., 2007) . The MEFs used were from both sexes together. The respiration by MEFs was assayed in intact and permeabilized cells. As expected, Complex I deficient S55A-MEFs showed 40e50% lower respiration rates than WT-MEFs on glucose þ pyruvate or pyruvate alone (Fig. 3A vs (Yadava et al., 2008) .
Phenotypic analysis of the Ndufa1 S55A mice
Complex I deficiency, in children with mitochondrial diseases, is often associated with "failure to thrive", which is monitored in mice by postnatal weight gain (Koene et al., 2011) . Therefore, to determine if systemic partial Complex I deficiency affected weight gain in postnatal mice; we measured weights of wild type and mutant littermate males after birth. Their weights were monitored from 7th to 11th week after birth. We observed no significant difference in weight gains of mutants and controls (Fig. 4A ). Even at later ages no significant difference in the weights of mutants and control mice were noted in either sex (not shown). Therefore, we conclude that the Ndufa1 S55A/Y mice thrive normally.
Complex I deficiency reduces the life-span of mitochondrial disease patients. Therefore, we assessed relative disease-free survival of the mutants compared to controls. We compared wild-type males (Ndufa1 þ/Y ) with mutant males (Ndufa1 S55A/Y ), wild-type fe-
), and both sexes together (wild-type vs. mutants). We noted opposite trends between the males vs. females (Fig. 4B vs. C) . The Complex I deficiency was associated with increased survival of mutant females ( Fig. 4C ; p ¼ 0.030). A trend of reduced survival was observed in males ( Fig. 4B ; p ¼ 0.096). When both sexes were combined, the differences between controls and mutants survival were minimal ( Fig. 4D ; p ¼ 0.083). These data suggest that Complex I deficiency can differentially affect the survival of male and female mice. The heterozygous females (Ndufa1 S55A/þ ) were not monitored. To determine the effect of Complex I deficiency on whole body metabolism, we measured respiratory exchange ratio (RER ¼ vCO 2 / vO 2 ) and body heat production. RER is an indicator of oxidative metabolism and fuel utilization. Littermate wild type and mutant males were compared. Our data suggest that mutant males were hypometabolic (Fig. 5A, Fig. 1S ). They showed lower RER in both light and dark phases of circadian cycle. Lower RER in mutants suggests that they burn more fats compared to controls. The RER patterns during light and dark phases also mirrored the patterns of body heat production (Fig. 5A vs. B) . The mutants consumed significantly less oxygen and spent less energy during both phases of circadian cycle (Fig. 1S B, C) . Thus reduced heat production is due to lower metabolism of the mutants. The mutant mice were less active compared to controls (Fig. 5C ). They also ate relatively less (Fig. 5D ). Both reduced physical activity and reduced feeding can contribute to lower heat production and energy expenditure. These data suggest that Ndufa1 S55A/Y mice are hypometabolic, hypoactive, and hypophagic.
Histopathological characterization of the Ndufa1 S55A mice
To determine histopathological consequence of Complex I deficiency in Ndufa1 S55A mice, we performed H & E staining of brain, liver, muscle and heart. These tissues heavily rely on oxidative metabolism. Although an exhaustive histopathological analysis is pending, our preliminary analyses revealed no notable differences in brains, livers, muscles and hearts of 3 months old mice (not shown). However in 14 month old male mice, we observed enhanced Purkinje neurons degeneration (Fig. 6 ). Visually more dead Purkinje neurons (dark pink) were evident in the mutants (S55A) compared to littermate controls (Fig. 6A) . In mutants, the Purkinje neurons death was about 4-fold higher (Fig. 6B) . The Purkinje neuron atrophy can lead to loss of motor co-ordination in mice and the clinical symptoms of ataxia in humans. Therefore, we respirations, respectively. 100,000 MEFs/well were spun down in V7 PS plates and measurements were made after 4 h of culture (n ¼ 5 wells/condition, mean ± SD).
measured relative motor activity of the mutants by rotarod tests. 14 months old control and mutant mice were subjected to rotarod tests. Despite a trend of mutants falling off the rod faster compared to littermate controls, the difference in latency to fall was not statistically significant (Fig. 6C ). This suggests that mutants may have minimal or no ataxia. However, it is possible that a more detailed gate analysis at various ages may reveal ataxic phenotype.
Effect of Complex I deficiency on the metabolic profiles of selected tissues
To determine the effect of Complex I deficiency on metabolic profiles, we performed metabolomic analysis with selected tissues. Tables 1, 2, and 3 show the lists of metabolites that were significantly different in mutants' brain, liver and serum, respectively. The number of metabolites displaying significant differences in brain and liver were less than expected by chance at p 0.05 (Fig. 7) . Additional metabolites approaching statistical significance (0.05 < p < 0.10) are also shown. In brain, the metabolites showing significant difference indicate alterations in the metabolism of branched chain amino acids, carnitine, and porphyrin pathways (Table 1) . In liver, they were indicative of alteration in metabolism of glutathione, amino acids, fatty acids, sterol/steroid, lipids, and co-factor metabolism ( Table 2 ). The analysis of serum metabolites suggested alterations in metabolism of amino acids, fatty acids, carnitine, lipids, purine and pyrimidines, nicotinate and nicotinamide, amino sugars, and porphyrin (Table 3) . Thus Complex I deficiency affects the metabolic profiles of tissues differentially.
We looked for the metabolites indicative of fatty acids oxidation because RER in mutants was lower (Fig. 5A) . Different long-chain fatty acids were relatively reduced in serums (Table 4) . This may be due to higher fatty acids oxidation in tissues. However, there was no build-up of the ketone body such as b-hydroxybutyrate in the serum. There was build-up of acylcarnitines in brain, which primary fuel is glucose. The 3-dehydrocarnitine, a degradation product of carnitine was elevated in all tissues. There was no compensatory decrease in the free carnitine in liver and serum. In brain, the decrease in carnitine was minimal. Since the metabolic profiles of muscle, heart and urine were not obtained, a clear estimation of the extent of fatty acids oxidation is not possible with our data. However, an increase in b-oxidation is observed in rotenone-treated SH-SY5Y human neuroblastoma cells (Worth et al., 2014) .
Complex I function is linked with glycolysis and the TCA cycle by NADH/NAD þ redox. The regeneration of NAD þ from NADH is essential for continued operation of both glycolysis and the TCA cycle. Therefore, we looked for the metabolites of glycolysis and the TCA cycle. Along with phosphoenol pyruvate (PEP , Table 1 ), other intermediates of glycolysis such as fructose 1, 6-diphosphate, and 3-phosphorglycerate were relatively higher in brain (Table 5) . There was no change in the brain lactate level. But serum lactate/ pyruvate ratio was relatively higher (1.41 fold, Table 5 ). Acetyl-CoA, citrate, fumarate, and malate levels were also higher in mutants. They may be due to increased glucose, amino acids and/or fatty acids oxidation in brain. In mutant livers, higher levels of maltohexose, maltose, maltotriose, maltotetraose, and maltopentaose were observed (Table 2 , and data not shown). This indicates increased glycogen catabolism, which was supported by relatively higher levels of glucose, glucose 6-phosphate, fructose 6-phosphate, pyruvate, and lactate in liver (Table 5) . Corticosterone, a hormone that regulates glucose homeostasis and inflammation, was also reduced in mutants liver and sera (Tables 2 and 3) . Together, these data suggest that partial Complex I deficiency may compromise glucose metabolism homeostasis. In brain, the metabolites that were significantly different between mutants and controls were isobutyrylcarnitine, 3-dehydrocarnitine, and heme (Table 1) . Along with isobutyrylcarnitine, the butyrylcarnitine level was also elevated (S55A/WT ratio: 1.29) suggesting that branched chain amino acids and short chain fatty acids metabolism were altered in mutants. The 3-dehydrocarnitine accumulation indicates carnitine's degradation, which corresponded with a mild decrease in free carnitine (Table 4, brain S55A/WT ratio: 0.87). The observation of heme reduction was interesting, because heme is a major functional form of iron inside cells. Heme deficiency is also linked with neurodegeneration (Atamna et al., 2002) . Like in brain, the level of heme was relatively reduced in liver and serum also (S55A/WT: brain 0.49, liver 0.4, and serum 0.88; Fig. 8AeC ). This suggested a global trend of heme deficiency in mutants. In serum, this was associated with a corresponding reduction in bilirubin, a catabolite from heme degradation (S55AS/WT: 0.19, p ¼ 0.040; Fig. 8D ). This suggests that reduced biosynthesis could be responsible for the lower heme level in mutants.
Two critical steps, the first and last steps of heme biosynthesis occur inside mitochondria. The last step is catalyzed by ferrochelatase (FECH), which puts ferrous iron into protoporphyrin IX. The protoporphyrin IX was not detected in any tissues in our analysis. This could be due to technical issues or the instability of the precursors. Therefore, we focused on the last step of the heme biosynthesis. To find if Fech expression was reduced, we performed quantitative RT-PCR. The Fech mRNA was monitored in liver and brain tissues along with the Hmox1 mRNA. We observed about 80% reduction in Fech mRNA expression in mutants' livers but not in the brains (Fig. 9A, C) . In contrast, Hmox1 mRNA expression was increased by 33e41% in both tissues (Fig. 9B, D) . These data suggest that Complex I deficiency can reduce heme synthesis by suppressing ferrochelatase in liver and up-regulating heme oxygenase in both liver and brain. Because other intermediates of the porphyrin were not detected in both wild-type and mutant tissues, the effect of Complex I deficiency on the first step of heme synthesis pathway mediated by d-aminolevulinic acid synthase (ALAS1, ALAS2) could not be excluded. The ALAS2 is erythroid-specific Xchromosome linked gene.
Discussion
Complex I deficiency is the most common cause of mitochondrial diseases. This may be due to a large number of genes involved , X/Y) and mutants (Ndufa1 S55A/Y, S55A/Y) males were analyzed with comprehensive laboratory animal monitoring system. All measured parameters were significantly reduced in the Ndufa1 S55A males compared to littermate controls (mean ± sem, *p < 0.05, t-test, n ¼ 7 at least in each group).
in Complex I biogenesis (Alston et al., 2017) . Of at least 58 Complex I related genes, the NDUFA1 and NDUFB11, are only two known Xchromosome-linked genes. An additional X-chromosome-linked gene is also predicted to be involved in Complex I biogenesis (Scheffler, 2015) . In this study, we describe an X-chromosome linked mouse model based on the knock-in of the Ndufa1 S55A allele for systemic partial Complex I deficiency. The Ndufa1 S55A harbors S55A mutation within the MWFE protein, which is essential for Complex I biogenesis (Au et al., 1999; Yadava et al., 2002) . The S55A mutation caused systemic partial Complex I deficiency in both sexes (Fig. 2) . Because the S55A mutation was introduced by a single nucleotide change in the 55th codon (T > G), it is analogous to a single nucleotide polymorphism (SNP). Thus studies with the Ndufa1 S55A model can inform us about how SNPs causing missense mutations in the Ndufa1 and other nuclear genes, affecting respiratory chain, Table 1 List of metabolites that differed in brains of control (WT) and mutant (S55A) male mice. Corresponding S55A/WT ratio of enlisted metabolites are shown at p 0.05 and at 0.05 < p < 0.10 (Welch's two-sample t-test, n ¼ 6 each group).
can influence pathophysiology. In humans, the NDUFA1 gene has 12 SNPs within the coding sequence causing 1 nonsense and 11 missense mutations (http://www.ncbi.nlm.nih.gov/SNP; NDUFA1; rs1801316). However, there are no SNPs or pathogenic mutations associated with serine-55. Despite the lack of a pathogenic mutation or SNP in the serine-55 codon, the Ndufa1 S55A model provides a unique resource to study the impact of systemic partial Complex I deficiency on pathophysiology. This is clearly evident from the observation that heme metabolism is affected by Complex I deficiency (Table 1 , Figs. 8 and 9 ). This observation is relevant toward understanding how Complex I deficiency resulting from the NDUFB11 mutations could cause sideroblastic anemia in humans (Lichtenstein et al., 2016; Torraco et al., 2017) . The sideroblastic anemia is caused by ferrochelatase (FECH) deficiency, which has several SNPs associated with it (Gouya et al., 1999; Rufenacht et al., 2001) . The Fech mRNA down-regulation by Complex I deficiency was observed across two different genetic backgrounds-129 ( Fig. 9C) and BALB/c (84 ± 9% lower, mean ± sem, n ¼ 4 each group, not shown). Thus Ndufa1 S55A model may be susceptible to sideroblastic anemia, which we plan to explore in our follow-up studies. The congenital sideroblastic anemia is predominantly Xchromosome-linked and for a majority of the cases the genetic defect remains unknown (Bergmann et al., 2010) . It is possible that the unidentified X-chromosome linked Complex I gene may be associated with some cases of congenital sideroblastic anemia. The NDUFA1-encoded MWFE is a small bipartite protein (70 amino acids) with an N-terminal import domain and a C-terminal functional domain. These two domains are separated by two glycine (G32 & G33) residues . Mutations in both domains are associated with mitochondrial disease with neurological symptoms. The G8R, P19S, G32R, and R37S mutations, which cause variable degree of Complex I deficiency, are linked with mitochondrial disease (Fernandez-Moreira et al., 2007; Mayr et al., 2011; Potluri et al., 2009; Uehara et al., 2014) . The P19S mutation caused over 60% decline in Complex I activity in skin fibroblasts and increased blood lactate and pyruvate levels in a 5 year old boy (Uehara et al., 2014) . The G32R mutation caused 90e95% decline in Complex I activity in muscles of 30e35 year old men with or without a mild increase in plasma lactate level (Potluri et al., 2009) . However, the same mutation showed only about 41% decline in Complex I-dependent respiration in Chinese lung fibroblasts (Potluri et al., 2009 ). In patients, mtDNA mutations Table 2 List of metabolites that differed in livers of control (WT) and mutant (S55A) male mice. Corresponding S55A/WT ratio of enlisted metabolites are shown at p 0.05 and at 0.05 < p < 0.10 (Welch's two-sample t-test, n ¼ 6 each group).
augmented G32R-dependent Complex I deficiency (Potluri et al., 2009) . This is in agreement with our previous study, which suggests that MWFE protein interacts with one or more of the mtDNAencoded Complex I subunits (Yadava et al., 2002 . The G32R heterozygous mutation was linked with mitochondrial disease in a girl due to higher expression of the mutant allele compared to wild type allele (Mayr et al., 2011) . The G8R and R37S mutations reduced Complex I activity in patients' muscles by at least 80% and 70%, and fibroblasts by 83% and 30% respectively (Fernandez-Moreira et al., 2007) . However, they caused 51% and 100% decline respectively in Complex I-dependent respiration in Chinese lung fibroblasts (Potluri et al., 2009 ). Thus apart from tissue-specific effects, the mutations in MWFE protein also have species-specific effects. This underscores the challenge in developing knock-in mice models for Complex I deficiency based on pathogenic mutations in humans. It is difficult to predict that the effects of pathogenic mutations observed in humans will be similar in mice. Therefore, focusing on Complex I deficiency, e.g.~50% as in this study, rather than exact pathogenic mutations is a rational approach toward understanding the pathophysiology of mitochondrial diseases associated with Complex I deficiency.
The species-specific effects of MWFE sequence played a major role in selection of the S55A mutation for developing the Ndufa1 S55A model. We have previously reported that significant differences exist between rodents and primates MWFEs. They cause incompatibility between nuclear and mitochondrial genomes during Complex I assembly (Yadava et al., 2002) . The serine 55 is conserved across evolution in rodents and primates. It resides outside the nucleo-mitochondrial incompatibility region defined by sitedirected mutagenesis (Yadava et al., 2002) . Further, the difference between mice and hamster cells were expected to be minimal because both belonged to the rodent group. Therefore, we predicted that S55A effects on Complex I would be comparable in hamsters and mice. Based on our previously reported data from Chinese hamster lung fibroblasts (Yadava et al., 2008) , about 50% isolated Complex I deficiency was expected in mouse cells/tissues. As expected, a similar level of Complex I deficiency was observed in mouse embryonic fibroblasts (MEFs; Fig. 3 ). Because the decline in Complex I activity of Ndufa1 S55A/Y tissues and cells is comparable to G8R and G32R mutations in hamster cells (41%e51%, see above), the Ndufa1 S55A model is suitable to assess the pathophysiologic effects of Complex I deficiency resulting from G8R and G32R mutations. The variable degree of Complex I deficiency in different tissues (Fig. 2) is similar to the variation observed in mitochondrial disease patients from a particular mutation. Neither S55A nor other mutations within the MWFE protein cause any defect downstream Table 3 List of metabolites that differed in sera of control (WT) and mutant (S55A) male mice. Corresponding S55A/WT ratio of enlisted metabolites are shown at p 0.05 and at 0.05 < p < 0.10 (Welch's two-sample t-test, n¼3 each group). (Yadava et al., , 2008 (Yadava et al., , 2002 . Therefore, the Ndufa1 S55A mice serve as models for isolated Complex I deficiency. While a detailed analysis of the downstream respiratory complexes from different tissues is pending, our preliminary analysis with liver mitochondria suggests that rest of the respiratory chain is normal (data not shown). This is supported by comparable Complex II-dependent respiration in WT-and S55A-MEFs (Fig. 3) . Currently, there are only a few models available for Complex I deficiency. Two of these are based on mutations in mtDNA-encoded Complex I subunit ND6 (Fan et al., 2008; Hashizume et al., 2012; Lin et al., 2012) . Others are based on nDNA-encoded genes such as AIF1, Ndufa5, Ndufs4, and Ndufs6. The Harlequin mouse (Aif Hq ) with a hypomorphic allele of apoptosis inducing factor (AIF) had been proposed as a model for Complex I deficiency (Benit et al., 2008) . However, a pathogenic AIF mutation in humans is not associated with Complex I deficiency. Rather AIF mutation results in Complexes III & IV deficiencies (Ghezzi et al., 2010) . The Ndufa5 genetrap based knock-out (Ndufa5
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) is embryonic lethal. However, brain specific Ndufa5 deletion causes a mild chronic encephalopathy in Ndufa5-CNS-KO mice (Peralta et al., 2014) . A few SNPs of the NDUFA5 gene are linked with autism (Marui et al., 2011) . The systemic knock-out of the NDUFS4 gene has provided the widely used Ndufs4
-/-mouse model. It displays progressive fatal encephalomyopathy (Kruse et al., 2008) . The pathological features of Ndufs4 -/-mice could also be recapitulated by the brain-specific knock-out in NesNdufs4 -/-mice, suggesting a critical role of Complex I in brain and overall health of an organism (Quintana et al., 2010) . A heterozygous (Ndufs4 þ/À ) mouse model bearing a point mutation resulting in truncated NDUFS4 protein has been also described (Ingraham et al., 2009 ), which results in heart failure (Ke et al., 2012) and renal disease (Forbes et al., 2013) . The Ndufa13 (GRIM19) knock-out is embryonic lethal in mice. However, in heterozygous mice innate immunity is compromised (Chen et al., 2012; Huang et al., 2004) . A pathogenic mutation in the Ndufa13 gene is linked with severe optic neuropathy and brain abnormalities (Angebault et al., 2015) . Because most of these models involve complete loss of the encoded proteins, they are good for modeling the consequences of severe Complex I deficiency. Unlike these models, the Ndufa1 S55A model is a knock-in model for milder Complex I deficiency. It is the only genuine model for X-chromosome linked Complex I deficiency. In contrast to knock-outs and gene-traps, it is based on introducing a single point mutation T > G within the coding region of the Ndufa1 gene. The FRT/LoxP footprint in the intron between exons 2 and 3 does not affect the expression of the Ndufa1 mRNA (not shown). Reduced whole body metabolism and Purkinje neurons degeneration in the male mice suggest that the Ndufa1 S55A model will serve as a suitable model for adult-onset mitochondrial diseases (Figs. 5 and 6). The symptoms of mitochondrial diseases in humans vs. mice due to Complex I deficiencies were recently reviewed (Koene et al., 2011) . A progressive mitochondrial disease such as Leigh syndrome is the most common clinical presentation in the presence of Complex I deficiency. The failure to thrive is often observed in children with mitochondrial diseases. Lower birth weights and reduced stature are associated with neurological disorders. Problems in breathing and intolerance to exercise due to multisystem involvement are common in mitochondrial disorders. Mitochondrial disease patients with mutations in NDUFA1 display most of these symptoms, which include developmental delay, early death, epilepsy, failure to thrive, abnormal breathing rhythm, abnormal MRI findings, dystonia, lactic acidosis, Leigh syndrome/brainstem dysfunction and psychomotor retardation. In the Ndufa1 S55A mice, systemic partial Complex I deficiency of~50% did not affect weight gain in post-natal mice despite the Ndufa1 S55A/Y mice were hypometabolic, hypophagic and hypoactive (Figs. 4 and 5) . It is interesting to note that despite relatively less feeding the mutants were able to maintain body weight comparable to controls (not shown).
Lower physical and metabolic activities along with lower body heat production may contribute to maintaining weight comparable to controls. However, it is possible that reduced body heat production may make mutants more susceptible to stressful conditions. The significantly reduced RER (vCO 2 /vO 2 ), oxygen consumption (vO 2 ), and energy expenditure (EE) observed in mutants suggests that these parameters offer an opportunity to devise non-invasive diagnostic tests in humans for systemic partial Complex I deficiency (Fig. 1S) . Neurological symptoms in mitochondrial disease patients include cerebellar ataxia, dementia, epilepsy, sensorineural deafness, and peripheral neuropathy (McFarland et al., 2010) . Brains from mitochondrial disease patients show atrophy and cortical lesions. Ischemic like lesions resembling stroke-penumbra without conformity to a vascular territory are observed in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS; (Iizuka et al., 2002) ). In MELAS neuronal hyper-excitability or pathological activation is suggested to be the underlying cause of ischemic-like lesions. However, the (Nicholls, 2017) . Glutamate can force neurons to respire at their full respiratory capacity (Yadava and Nicholls, 2007) . Therefore, even minimal Complex I deficiency can increase neuronal susceptibility to excitotoxic death. This may be the reason why neurological problems are the most common features of mitochondrial diseases. Purkinje neurons in Ndufa1 S55A mice may be more susceptible to excitotoxic stimulation due to their extensive branching and synaptic structures. While our data suggest that Purkinje neuron death in mutants is higher (Fig. 6) , it remains to be determined whether it is due to excitotoxic death. Condensation of nuclei following Ca 2þ deregulation is a hallmark of excitotoxic death (Vesce et al., 2004) . By this criterion, it appears that in Ndufa1 S55A mice Purkinje neurons, which also express NMDA receptors, may be undergoing excitotoxic death (Piochon et al., 2010) . Because iron deregulation is linked with excitotoxic vulnerability (Cheah et al., 2006; Chen et al., 2013) , the impaired heme metabolism in brain could be relevant to neurodegeneration in the presence of Complex I deficiency (Table 1) . Whether histopathology is selective to Purkinje neurons also remains to be determined by exhaustive phenotyping. The effect of missense NDUFA1 mutations can be phenotypically exacerbated by mild variants of mtDNA-encoded Complex I subunits (Potluri et al., 2009) . This is because the Ndufa1-encoded MWFE subunit is a key determinant of nucleo-mitochondrial incompatibility (Mishmar et al., 2006; Yadava et al., 2002) . The Ndufa1 S55A model will enable to test how mtDNA haplotype differences amplify or suppress Complex I deficiency. This can be achieved by transferring the Ndufa1 S55A allele to mice with different mtDNA backgrounds such as ND6 P25L mutant (Lin et al., 2012) . MtDNA confers strain-specific difference in aging phenotypes on the same nuclear background (Latorre-Pellicer et al., 2016).
The Complex I regulation by protein kinase-A is also implicated in sensitivity to cannabinoids (Hebert-Chatelain et al., 2016) . It is possible that Ndufa1 S55A show enhanced sensitivity to cannabinoids because MWFE protein is also regulated by PKA (Chen et al., 2004; Yadava et al., 2008) . The serine-55 within MWFE protein is a target for protein kinase A (Chen et al., 2004; Yadava et al., 2008) . Thus, the Ndufa1 S55A mice will serve as a unique tool to decipher the role of regulated MWFE phosphorylation in mitochondrial bioenergetics. In addition, Ndufa1 S55A mice may find applications in predicting in vivo drug toxicity because reduced Complex I level may increase sensitivity to drugs with mitochondrial side-effects (Wallace, 2015; Wallace and Starkov, 2000) . The number of metabolites that differed significantly between controls and mutants brain and liver were less than expected by change (a error p ¼ 0.05). This may be due to individual-specific differences in metabolomes. The principal component analysis revealed considerable sample heterogeneity regardless of the genotype (not shown). Despite samples heterogeneity, the observed differences may be real, because metabolites varying by chance will be different in each individual and group (e.g. WT vs. S55A). Further, inferences about affected pathways could be made on the basis of the trends of metabolites within a pathway of interest with supplementary analyses. Our focus on heme metabolism with supporting gene expression data suggests that metabolites signatures in brain and liver are the consequence of Complex I deficiency. Over 80% reduction in Fech mRNA was observed on two different genetic backgrounds (129, BALB/c). This could be an adaptive response to Complex I deficiency. Although, Complex I does not contain heme as co-factor, previous studies have suggested ferrochelatase association with Complex I (Taketani et al., 1986) . A metabolomic and proteomic analysis of rotenone-treated HeLa cells also suggests that Complex I deficiency can impair heme metabolism (Gielisch and Meierhofer, 2015) . Tissue-specific alterations in amino acids, lipids and redox metabolism are also found in humans with Leigh syndrome (Thompson Legault et al., 2015) . Although Ndufa1 S55A/Y mice metabolomic analysis is different from humans, the results show tissue-specific metabolic signatures (Tables 1e3). Whether metabolic signatures between both sexes are similar remains to be determined. In summary, Ndufa1 S55A is a genuine X-chromosome-linked mouse model for systemic partial Complex I deficiency. Mutant males show reduced respiratory exchange ratio (RER) and generate less body heat. They are also hypoactive and hypophagic. The older mice show Purkinje neurons degeneration in the cerebellum. The opposite survival patterns of mutant males and mutant females suggest that X-chromosome-linked Complex I deficiency can cause sex bias in clinical presentations of mitochondrial diseases ( Fig. 4B  and C) . Future studies dealing with complete histopathological characterization with aging may reveal the underlying basis for the difference in survival of males and females. Estrogen signaling may be responsible for sex-dependent survival and pathophysiology (Pedram et al., 2006; Pisano et al., 2015) . Metabolic signatures and oxidative and redox stresses resulting from the same level of Complex I deficiency may vary between the two sexes. The metabolomic analysis of brain, liver, and serum from males revealed tissue-specific signatures of Complex I deficiency. They suggested a systemic heme deficiency, which correlated with reduced ferrochelatase (Fech) expression in liver and increased heme oxygenase (Hmox1) expression in brain and liver. Dopamine elevation may cause neurological changes in mice mimicking psychosis (Table 1 ; (Dandash et al., 2017) ). Our studies have linked Complex I deficiency with tumor suppressor p53 (Compton et al., 2011) and mesenchymal stem cells susceptibility to glucotoxicity (Sen et al., 2015) , which are relevant to development of cancer and diabetes. Therefore, we believe that the Ndufa1 S55A model will find wide applications in testing predispositions to spontaneous and stress-induced diseases such as neurodegeneration, cancer and diabetes.
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